Viropharma Inc (VPHM) Return on Equity ROE from the third quarter 2013 to third quarter 2012 and annually, average high and low, overall ranking from Sep 30 2013 to Sep 30 2012 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Viropharma Inc  (VPHM)

Viropharma Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Viropharma Inc in the third quarter 2013?
Viropharma Inc recorded a cumulative net loss of $-63 million during 12 months ending in the third quarter 2013, resulting in a negative return on equity (ROE) of -8.73%.

Within the Biotechnology & Pharmaceuticals industry 11 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2013 from 0 to 1872.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Equity Change -6.94 % -17.17 % -20.16 % -15.05 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -63 -72 -77 9 43
Return On Equity (TTM) -8.73 % -9.76 % -9.91 % 1.12 % 5.09 %
VPHM's Total Ranking # 1872 # 0 # 0 # 0 #
Equity (TTM) in Millions 728 710 701 757 782
Seq. Equity Change 2.55 % 1.32 % -7.46 % -3.22 % -8.71 %
Seq. Net Income Change 600 % - - - -

Back to VPHM Management Effectiveness >> VPHM's 5 Years Annual ROE >> Compare VPHM ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 12
Sector # 108
Overall # 1872

Return On Equity Statistics
High Average Low
-0.51 %
-1.04 %
-1.57 %
(Sep 30 2013)   (Jun 30 2013)





VPHM Annual Return On Equity (Dec 31 2012)
2012		 (Dec 31 2009)
2011


Total Equity in Millions 757 891 0 0 0
Y / Y Equity Change -15.05 % - - - -
Net Income in Millions 6 -11 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 0.74 % -1.24 % - - -

Back to VPHM Management Effectiveness >> VPHM's 5 Years Annual ROE >> Compare VPHM ROE to its Competitors




Annual Roe Comment
In 2012 ROE improved to 0.74 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
VPHM's' Return on Equity at Yahoo Finance
VPHM's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for VPHM's Competitors
Subscribers only: Roe for Viropharma Inc's Suppliers
Subscribers only: Return On Equity for VPHM's Customers




Companies with similar Return On Equity at Sep 30 2013, within Healthcare Sector ROE

Date modified: 2026-09-08T15:07:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.